| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |